Cancers | Free Full-Text | The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials | HTML
Select clinical trials evaluating avelumab in combination with other... | Download Table
Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma - Kazandjian - 2021 - The Oncologist - Wiley Online Library
Avelumab timeline from discovery to Merck-Pfizer Alliance, breakthrough... | Download Scientific Diagram
Select clinical trials evaluating avelumab in combination with other... | Download Table
Avelumab timeline from discovery to Merck-Pfizer Alliance, breakthrough... | Download Scientific Diagram
![PDF] Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/63896bbe64c237acb7d4260c2e84ab3aa4969933/29-Table2-1.png "PDF] Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy | Semantic Scholar")
PDF] Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy | Semantic Scholar
Multicenter Clinical Trial is Currently Recruiting MCC Patients - Merkel Cell Carcinoma
Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer - Cancer Treatment Reviews
Avelumab Versus Docetaxel in Patients With Platinum-Treated Advanced NSCLC: 2-Year Follow-Up From the JAVELIN Lung 200 Phase 3 Trial - Journal of Thoracic Oncology
2018-1357
![PDF] Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/63896bbe64c237acb7d4260c2e84ab3aa4969933/35-Figure1-1.png "PDF] Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy | Semantic Scholar")
PDF] Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy | Semantic Scholar
Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy - Annals of Oncology
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma | NEJM
![PDF] Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/63896bbe64c237acb7d4260c2e84ab3aa4969933/38-Figure3-1.png "PDF] Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy | Semantic Scholar")
PDF] Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy | Semantic Scholar
Clinical Trial Goss - BioCanRx
Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial - Lung Cancer
ASCO 2020: JAVELIN Bladder 100 Phase III Results: Maintenance Avelumab + Best Supportive Care vs BSC Alone After Platinum-Based First-Line Chemotherapy in Advanced Urothelial Carcinoma
Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice - Cancer Treatment Reviews
Hutson Compares Avelumab for PD-L1 Positive Versus PD-L1 Negative Bladder Cancer
Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data | Scientific Reports
Anti-PD-L1 antibodies atezolizumab, avelumab and durvalumab currently... | Download Scientific Diagram
Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy - Annals of Oncology
Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial - European Urology
